US Broker Ratings

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 38% Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) an intriguing candidate, particularly given its potential upside of 38.24%. With..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a Biotech with Strong Buy Ratings and Promising Clinical Pipeline

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising name in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling cardiorenal diseases..

AtriCure, Inc. (ATRC)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Potential Upside in Healthcare Innovation

Azenta, Inc. (NASDAQ: AZTA) is positioned at the intersection of healthcare innovation, offering a range of biological and chemical compound sample management solutions. With a market..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Promising 35% Upside in the Healthcare Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA) is carving out a significant niche in the healthcare sector with its innovative medical devices tailored for aesthetic and reconstructive..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unveiling an 84.95% Potential Upside Amid Biotech Innovations

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands out in the biotechnology sector by leveraging its innovative bioresorbable hydrogel-based formulation technology to tackle retinal diseases and other ocular..

Immunocore Holdings plc (IMCR) Stock Analysis: Navigating a Potential 92% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR), a compelling player within the biotechnology sector, has caught the attention of the investment community with its promising pipeline of immunotherapies..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) represents a promising investment opportunity in the healthcare sector, particularly for those focusing on innovative fertility and family-building solutions. With a market..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Highs of a $2.54 Billion Market Cap with a Potential Downside

GRAIL, Inc. (NASDAQ: GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing investor attention with its pioneering multi-cancer early..

National HealthCare Corporation (NHC): Unpacking the Growth Potential in a Thriving Healthcare Sector

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, stands out with its comprehensive range of services spanning skilled nursing facilities, assisted and..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 140% Potential Upside Amidst Challenges

Opko Health, Inc. (NASDAQ: OPK), a healthcare company specializing in diagnostics and pharmaceuticals, presents an intriguing prospect for investors willing to navigate the complexities of its..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Promising Growth in Autoimmune Therapeutics Sector

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology firm, has captured investor attention with its innovative approach to treating autoimmune diseases, particularly through its flagship product,..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Potential 68.58% Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is capturing investor attention with a compelling potential upside of 68.58%, according to recent analyst ratings. As a key player in..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a Potential 11% Upside

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the burgeoning field of virtual healthcare, offers a compelling yet complex picture for potential investors. With a..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a 186.67% Potential Upside in the Biotech Arena

Investors with a keen eye on the healthcare sector might find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. As a burgeoning player in the biotechnology..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals 168.74% Upside Potential

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical powerhouse in the biotechnology industry, is capturing investor attention with its promising pipeline focused on rare and ultra-rare genetic..

Disc Medicine, Inc. (IRON) Stock Analysis: Analyst Ratings Shine with a 38.59% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) has captured the attention of investors with its promising pipeline in the biopharmaceutical landscape. As a clinical-stage biotech company, it stands..

Supernus Pharmaceuticals (SUPN): Investor Outlook on a Promising 12% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unveiling a 20.66% Upside Potential for Investors

For investors looking to diversify their portfolios with a robust healthcare play, U.S. Physical Therapy, Inc. (NYSE: USPH) offers a compelling opportunity. Headquartered in Houston, Texas,..

Tandem Diabetes Care, Inc. (TNDM)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds